BOSTON, April 2 -- Claudia I. Henschke, M.D., Ph.D., principal investigator of the controversial 2006 I-ELCAP (International Early Lung Cancer Action Program) study, has formally disclosed to the medical community that tobacco-industry money funded the study.
In a letter published online in the New England Journal of Medicine, Dr. Henschke said "$3.6 million . . . was contributed in 2000 through 2003 as an unrestricted gift by the Vector Group, the parent company of Liggett Tobacco, which manufactures cigarettes."
The New England Journal of Medicine has also issued an online correction and a clarification regarding the once-again controversial study of spiral CT detection of lung cancer.
Last week, the New York Times reported that funding for the study by Dr. Henschke and colleagues at Weill Cornell Medical Center in New York had been channeled through a foundation set up by Dr. Henschke and officials at Weill Cornell (See: Early Lung Cancer Study Found Funded by Tobacco Money). /.../
No comments:
Post a Comment